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Objectives
To quantify placebo effect through a systemic review of
juvenile idiopathic arthritis (JIA) trials using placebo as
comparator.
Methods
This study was developed according to the PRISMA
statement and pre-specified study selection, eligibility
criteria, data extraction, quality assessment, and statisti-
cal analysis. Studies with parallel, cross-over or withdra-
wal design (open label followed by a double-blind
placebo withdrawal period) were included in the analy-
sis. Publications were retrieved from MEDLINE, Web of
Science, EMBASE, and the Cochrane Controlled Trials
Register from 1960 to May 2010, with literature search
carried out from February to December 2010. Estimates
of the placebo response rate and estimates of the pla-
cebo flare rate for the withdrawal trials with 95% Confi-
dence Intervals (CI) were calculated.
Results
A total of 10 out of 18 trials were included in the final
meta-analysis synthesis. In the 5 trials with parallel
design the number of responders among the patients
randomized to the placebo arms were 76/246 (30.7%)
for recent studies with composite scores such as the
ACR pediatric 30 criteria with a pooled placebo effect
estimate (fixed effect method) equal to 30% (95% CI 24-
36%).
In the5 withdrawal design trials the number of flared
patients randomized to the placebo arms was 89/123
(72.4%) with a pooled effect estimates (percentages of
placebo patients who have a flare during the double
blind phase in the placebo group) equal to 74% (95% CI
67-82%).
Conclusions
This systematic review provides reference data for the
mean placebo effect for parallel trials and mean placebo
flare rate for trials with withdrawal design.
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